10.25  0.05 (0.49%)		01-27 15:06
Open: 10.17 High: 10.25 Volume: 730		Pre. Close: 10.2 Low: 10.17 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	12.28	1-year :	12.55
Resists	First :	10.51	Second :	10.74
Pivot price	10.36
Supports	First :	10.14	Second :	8.43
MAs	MA(5) :	10.25	MA(20) :	10.34
	MA(100) :	10.18	MA(250) :	10.15
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	13.9	D(3) :	13.9
RSI	RSI(14): 46.7
52-week	High :	10.74	Low :	9.35

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ FOXW ] has closed above bottom band by 34.3%. Bollinger Bands are 151.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	10.27 - 10.32	10.32 - 10.37
Low:	10.11 - 10.18	10.18 - 10.23
Close:	10.15 - 10.26	10.26 - 10.34

FoxWayne Enterprises Acquisition Corp. does not have significant business. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biotechnology and/or telemedicine sector of the healthcare industry in North America. The company was incorporated in 2020 and is based in New York, New York.

Tue, 20 Sep 2022
Live Streaming Social Entertainment Platform Powering the Creator Economy, Clover Inc., to Merge with Special ... - PR Newswire

Mon, 07 Mar 2022
SPAC FoxWayne, Aerami Therapeutics call off merger due to market conditions - Seeking Alpha

Fri, 04 Mar 2022
Aerami Therapeutics Holdings, Inc. and FoxWayne Enterprises Acquisition Corp. Mutually Agree to Terminate Business ... - PR Newswire

Tue, 14 Dec 2021
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils $250M SPAC deal - FiercePharma

Tue, 07 Dec 2021
Innovative Inhaled Drug Delivery Developer Aerami Therapeutics to Merge with Special Purpose Acquisition Company ... - PR Newswire

Thu, 26 Aug 2021
Big SPAC Redemptions and Price Jumps Continue - TheStreet

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	1 (M)
Shares Float	1 (M)
Held by Insiders	0 (%)
Held by Institutions	67.1 (%)
Shares Short	1 (K)
Shares Short P.Month	2 (K)

EPS	0.34
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-1.74
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	30.14
PEG Ratio	0
Price to Book value	-5.93
Price to Sales	0
Price to Cash Flow	-23.61

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.